Abstract
Hematological malignancies are considered to be one of the most important causes of mortality and morbidity in the modern world. Still, important progress has been made in the last decade due to breakthroughs in hematopoietic stem cell transplantation and cellular therapies.
The results of these recent studies show that a promising road toward state-of-the-art treatment for the hematology patient, turning the diagnosis of leukemia or lymphoma into a curable disease, has already begun, with recent advances in hematopoietic stem cell transplantation and immunotherapy, and is now progressing forward. The prospect of providing a definitive alternative therapy for various malignancies, rather than conventional chemotherapy management, is indeed clinically, socially, and economically attractive, due to the huge medical, social, and economic burden that a malignancy imposes.